Orforglipron
Orforglipron is a weight management peptide used in evidence-based, physician-supervised protocols. First-line oral weight loss when patient refuses injectable GLP-1, or as bridge therapy.
What is Orforglipron?
Non-peptide small-molecule oral GLP-1 receptor agonist. Activates GLP-1R to suppress appetite, slow gastric emptying, increase insulin secretion, and reduce glucagon. Fully oral — bypasses injectable peptide limitations. TITRATION PROTOCOL: 3mg x14 days → 6mg x14 days → 12mg x14 days → 24-45mg maintenance.
Uses & clinical decision logic
First-line oral weight loss when patient refuses injectable GLP-1, or as bridge therapy. Take on empty stomach 30 min before food.
Orforglipron dosage & administration
| Vial size | BAC water | Dosing range | Units / dose | Frequency | Route |
|---|---|---|---|---|---|
| Oral Cap | N/A (oral) | 3-45mg | 1 capsule | 1x/day | Oral |
Safety & contraindications
Same class as semaglutide — nausea/vomiting at initiation; titrate carefully. Contraindicated in pancreatitis history, MEN2/MTC.
Stacking & combinations
Do not combine with injectable semaglutide/tirzepatide simultaneously. Can add AOD-9604 or 5-Amino-1MQ for complementary mechanisms.
Related peptides
Frequently asked questions
What is Orforglipron used for?
First-line oral weight loss when patient refuses injectable GLP-1, or as bridge therapy. Take on empty stomach 30 min before food.
What is the typical Orforglipron dosage?
Common dosing ranges from 3-45mg (1x/day, Oral). Exact dosing is individualized and set by a licensed physician.
How is Orforglipron administered?
Orforglipron is typically administered via Oral.
What are the contraindications for Orforglipron?
Same class as semaglutide — nausea/vomiting at initiation; titrate carefully. Contraindicated in pancreatitis history, MEN2/MTC.
Build a physician-supervised protocol around your goal — no gatekeeping, real doctors, 503A compounding pharmacies.
Build your protocol →This page is for educational purposes only and is not medical advice. Peptide therapies described here are provided under physician supervision through 503A compounding pharmacies. Many peptides are not FDA-approved for the uses described. Do not start, stop, or change any protocol without consulting a licensed physician.